Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03776136 |
|---|---|
| Brief Title: | Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) for Advanced Melanoma in Anti-Programmed Death-1/Programmed Death-Ligand 1 (PD-1/L1)-Exposed Participants (MK-7902-004/E7080-G000-225/LEAP-004) |
| First Submitted : | December 13, 2018 |
| First Submitted that Met QC Criteria : | December 13, 2018 |
| First Posted : | December 14, 2018 |
| Last Update Submitted that Met QC Criteria : | October 16, 2023 |
| Last Update Posted : | October 17, 2023 |